Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Hiroaki, Mashima"'
Autor:
Tomoyuki Abe, Tsuyoshi Kobayashi, Shintaro Kuroda, Michinori Hamaoka, Hiroaki Mashima, Takashi Onoe, Naruhiko Honmyo, Koichi Oishi, Hideki Ohdan
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Severe acute cholecystitis (AC) is a challenging disease because it comprises coexisting systemic infections that lead to vital organ dysfunction. This study evaluated the optimal surgical timing and efficacy of preoperative percu
Externí odkaz:
https://doaj.org/article/339e231e6153467695f6d0f2abd4483f
Autor:
Yohei Mizusawa, Hiroyuki Sawada, Hitoshi Idani, Kanyu Nakano, Masanori Yoshimitu, Akito Shimizu, Yuta Une, Hiroaki Mashima, Masashi Yoshimoto, Yuki Katsura, Michihiro Ishida, Daisuke Satoh, Ryuichi Yoshida, Yasuhiro Choda, Yasuhiro Shirakawa, Hiroyoshi Matukawa, Shigehiro Shiozaki
Publikováno v:
American Journal of Case Reports; 9/29/2024, Vol. 25, p1-6, 6p
Autor:
Hiroaki Mashima, Rong Zhang, Tsuyoshi Kobayashi, Hirotake Tsukamoto, Tianyi Liu, Tatsuaki Iwama, Yuichiro Hagiya, Masateru Yamamoto, Satoshi Fukushima, Seiji Okada, Alimjan Idiris, Shin Kaneko, Tetsuya Nakatsura, Hideki Ohdan, Yasushi Uemura
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 21, Iss , Pp 171-179 (2021)
The tumorigenicity and toxicity of induced pluripotent stem cells (iPSCs) and their derivatives are major safety concerns in their clinical application. Recently, we developed granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing prolif
Externí odkaz:
https://doaj.org/article/56ea2a8f25684d90bfd5080dffd495c7
Autor:
Satoshi Fukushima, Azusa Miyashita, Haruka Kuriyama, Toshihiro Kimura, Satoru Mizuhashi, Yosuke Kubo, Satoshi Nakahara, Hisashi Kanemaru, Nobuhiro Tsuchiya, Hiroaki Mashima, Rong Zhang, Yasushi Uemura
Publikováno v:
Experimental Dermatology. 32:290-296
Cancer immunotherapy is now the first-line treatment for many unresectable cancers. However, it remains far from a complete cure for all patients. Therefore, it is necessary to develop innovative methods for cancer immunotherapy, and immune cell ther
Autor:
Hiroaki Mashima, Rong Zhang, Tsuyoshi Kobayashi, Yuichiro Hagiya, Hirotake Tsukamoto, Tianyi Liu, Tatsuaki Iwama, Masateru Yamamoto, Chiahsuan Lin, Ryusuke Nakatsuka, Yuta Mishima, Noriko Watanabe, Takashi Yamada, Satoru Senju, Shin Kaneko, Alimjan Idiris, Tetsuya Nakatsura, Hideki Ohdan, Yasushi Uemura
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Immunotherapy using dendritic cells (DCs) is a promising treatment modality for cancer. However, the limited number of functional DCs from peripheral blood has been linked to the unsatisfactory clinical efficacies of current DC-based cancer immunothe
Externí odkaz:
https://doaj.org/article/97057ff2950a43e8858f76e78e9bec65
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0217586 (2019)
The utility of glypican-3 (GPC3) expression for the detection of circulating tumor cells (CTCs) in hepatocellular carcinoma (HCC) patients has not been elucidated. The aim of this study was to identify associations between the presence of GPC3-positi
Externí odkaz:
https://doaj.org/article/44932f3039aa4a6dbda2b26a95fe36ff
Autor:
Shintaro Kuroda, Daisuke Takei, Hiroaki Mashima, Tsuyoshi Kobayashi, Masakazu Hashimoto, Hideki Ohdan, Keiso Matsubara
Publikováno v:
Annals of Medicine and Surgery
Background While the adoption rates of laparoscopic hepatectomy are increasing, most patients still undergo open hepatectomy. Open hepatectomies use inverted L-shaped or Mercedes incisions for right-sided liver tumor. To decrease procedural invasiven
Autor:
Hideki Ohdan, Seiji Okada, Hirotake Tsukamoto, Tatsuaki Iwama, Hiroaki Mashima, Shin Kaneko, Satoshi Fukushima, Alimjan Idiris, Yuichiro Hagiya, Masateru Yamamoto, Tetsuya Nakatsura, Tianyi Liu, Yasushi Uemura, Rong Zhang, Tsuyoshi Kobayashi
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 21, Iss, Pp 171-179 (2021)
Molecular Therapy: Methods & Clinical Development, Vol 21, Iss, Pp 171-179 (2021)
The tumorigenicity and toxicity of induced pluripotent stem cells (iPSCs) and their derivatives are major safety concerns in their clinical application. Recently, we developed granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing prolif
Autor:
Hideki Ohdan, Daiki Miki, Hiroaki Mashima, Michinori Hamaoka, Hiroshi Aikata, Kazuaki Chayama, Masateru Yamamoto, Shintaro Kuroda, Tsuyoshi Kobayashi
Publikováno v:
International journal of surgery (London, England). 80
Background This study examined whether single nucleotide polymorphism (SNP) in programmed cell death protein (PD)-1 is related to the postoperative prognosis of patients with hepatocellular carcinoma (HCC). The immune checkpoint protein PD-1 is an im
Autor:
Takashi Yamada, Hirotake Tsukamoto, Shin Kaneko, Yasushi Uemura, Satoru Senju, Hiroaki Mashima, Masateru Yamamoto, Tsuyoshi Kobayashi, Ryusuke Nakatsuka, Chiahsuan Lin, Tatsuaki Iwama, Yuichiro Hagiya, Yuta Mishima, Rong Zhang, Tianyi Liu, Tetsuya Nakatsura, Alimjan Idiris, Hideki Ohdan, Noriko Watanabe
Publikováno v:
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 9, Iss 1 (2020)
article-version (VoR) Version of Record
OncoImmunology, Vol 9, Iss 1 (2020)
Immunotherapy using dendritic cells (DCs) is a promising treatment modality for cancer. However, the limited number of functional DCs from peripheral blood has been linked to the unsatisfactory clinical efficacies of current DC-based cancer immunothe